Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

August 01, 1991; Volume 258,Issue 2
  • You have access
    Energetic aspects of the regulation of Ca++ sensitivity of permeabilized rabbit mesenteric artery: possible involvement of a second Ca++ regulatory system in smooth muscle contraction.
    J Nishimura and C van Breemen
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 397-402;
  • You have access
    Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats.
    K Elrod and J J Buccafusco
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 403-409;
  • You have access
    Selective effects of acute and chronic ethanol exposure on neuropeptide and guanine nucleotide stimulated phospholipase C activity in intact N1E-115 neuroblastoma.
    T L Smith
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 410-415;
  • You have access
    The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
    S C Black, L G Chi, D X Mu and B R Lucchesi
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 416-423;
  • You have access
    [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor.
    T Huo and D P Healy
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 424-428;
  • You have access
    Action of adenosine in estrogen-primed nonpregnant guinea pig myometrium: characterization of the smooth muscle receptor and coupling to phosphoinositide metabolism.
    W P Schiemann, K O Doggwiler and I L Buxton
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 429-437;
  • You have access
    Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
    Y Takano and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 438-446;
  • You have access
    Antagonistic effect of amiloride on alpha-2 adrenoceptor-mediated pigment aggregation: pharmacological heterogeneity between B-HT 920 and noradrenaline.
    S P Svensson, L G Mårtensson, N Grundström, R G Andersson, E J Cragoe and J O Karlsson
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 447-451;
  • You have access
    Contribution of K+ channels to arachidonic acid-induced endothelium-dependent vasodilation in rat isolated perfused mesenteric arteries.
    A S Adeagbo and K U Malik
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 452-458;
  • You have access
    Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood-brain barrier.
    T Shimura, S Tabata, T Ohnishi, T Terasaki and A Tsuji
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 459-465;
  • You have access
    L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
    Y Goshima, S Nakamura and Y Misu
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 466-471;
  • You have access
    Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance.
    L Beani, C Bianchi, L Ferraro, M Morari, M Simonato, G Spalluto and S Tanganelli
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 472-476;
  • You have access
    Cocaine pharmacokinetics in the pregnant guinea pig.
    J A Sandberg and G D Olsen
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 477-482;
  • You have access
    Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats.
    W Löscher and C Rundfeldt
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 483-489;
  • You have access
    Adenosine A1 and A2 receptors mediate presynaptic inhibition and postsynaptic excitation in guinea pig submucosal neurons.
    C Barajas-Lopez, A Surprenant and R A North
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 490-495;
  • You have access
    Age-related differences in the effects of some muscarinic agents on acetylcholine release from rat neostriatal slices.
    H J Lee, N V Cozzi and M H Weiler
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 496-501;
  • You have access
    Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
    C P France, G Winger, F Medzihradsky, M R Seggel, K C Rice and J H Woods
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 502-510;
  • You have access
    Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels.
    H N Bhargava, V M Villar, A Gulati and G Chari
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 511-516;
  • You have access
    Spinal and supraspinal components of cannabinoid-induced antinociception.
    A H Lichtman and B R Martin
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 517-523;
  • You have access
    Endothelin and calcium signaling in NG108-15 neuroblastoma x glioma cells.
    J Chan and D A Greenberg
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 524-530;
  • You have access
    Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes.
    J T Shirley and J B Cheng
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 531-536;
  • You have access
    Mechanisms for the uptake of cationic drugs by the liver: a study with tributylmethylammonium (TBuMA).
    H Steen, R Oosting and D K Meijer
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 537-543;
  • You have access
    Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
    E Mjanger and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 544-550;
  • You have access
    Naltrexone modulation of nicotinic acetylcholine receptor activity.
    A C Le Dain, B W Madsen and R O Edeson
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 551-558;
  • You have access
    Interaction between methotrexate, "rescue" agents and cell proliferation as modulators of homocysteine export from cells in culture.
    H Refsum, B Christensen, R Djurhuus and P M Ueland
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 559-566;
  • You have access
    The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    A Floch, L Tahraoui, P Sedivy and I Cavero
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 567-575;
  • You have access
    Evidence for central alpha-2 adrenoceptors, not imidazoline binding sites, mediating the ethanol-attenuating properties of alpha-2 adrenoceptor antagonists.
    M J Durcan, R G Lister and M Linnoila
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 576-582;
  • You have access
    Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    A Mattia, T Vanderah, H I Mosberg and F Porreca
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 583-587;
  • You have access
    Caffeine and theophylline as adenosine receptor antagonists in humans.
    I Biaggioni, S Paul, A Puckett and C Arzubiaga
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 588-593;
  • You have access
    Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
    D A Di Monte, E Y Wu, I Irwin, L E Delanney and J W Langston
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 594-600;
  • You have access
    Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice.
    M Morigi, D Macconi, E Riccardi, P Boccardo, P Zilio, T Bertani and G Remuzzi
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 601-606;
  • You have access
    Activation of phospholipase D by E-series prostaglandins in human erythroleukemia cells.
    H Wu, J T Turner and S P Halenda
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 607-612;
  • You have access
    Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
    N Bakry, Y Kamata, R Sorensen and L L Simpson
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 613-619;
  • You have access
    Lipolytic activity of progesterone and synthetic progestins on rat parametrial adipocytes in vitro.
    V Dorai, M C Hazard, J Paris and R Delansorne
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 620-625;
  • You have access
    Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    K F Melia and R D Spealman
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 626-632;
  • You have access
    Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem.
    L Grundemar, C Wahlestedt and D J Reis
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 633-638;
  • You have access
    Inhibitory effects of substance P and carbachol on the saturable sodium-dependent uptake process of myo-inositol in rat parotid gland.
    Y Torrens, M Dietl, J C Beaujouan and J Glowinski
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 639-646;
  • You have access
    Purified choleragenoid does not induce migrating action potential complex activity in rabbit ileum in vivo.
    C D Lind, R L Guerrant, A Kurosky and J R Mathias
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 647-651;
  • You have access
    Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    G C Yaney, G A Stafford, J D Henstenberg, G W Sharp and G A Weiland
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 652-662;
  • You have access
    Baclofen and adenosine inhibit synaptic potentials mediated by gamma-aminobutyric acid and glutamate release in rat nucleus accumbens.
    N Uchimura and R A North
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 663-668;
  • You have access
    Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release.
    W H Folger, D Lawson, C S Wilcox and J L Mehta
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 669-675;
  • You have access
    Effect of accumulation of NKY-722, a water-soluble vasoselective Ca++ antagonist, on KCl-induced contraction in isolated canine mesenteric arteries.
    H Shimaji, H Shirahase, M Kanda, S Osumi and K Kurahashi
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 676-680;
  • You have access
    A WB 4101-sensitive alpha-1 adrenergic receptor subtype modulates repolarization in canine Purkinje fibers.
    J H Lee, S F Steinberg and M R Rosen
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 681-687;
  • You have access
    U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.
    E D Hall, J M Braughler, P A Yonkers, S L Smith, K L Linseman, E D Means, H M Scherch, P F Von Voigtlander, R A Lahti and E J Jacobsen
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 688-694;
  • You have access
    Presystemic and systemic chiral inversion of R-(-)-fenoprofen in the rat.
    B W Berry and F Jamali
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 695-701;
  • You have access
    Identification of a 17-kDa protein associated with the peripheral-type benzodiazepine receptor in vascular and other smooth muscle types.
    D A Cox, P T Ellinor, T L Kirley and M A Matlib
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 702-709;
  • You have access
    Studies of concanavalin A in nonobese diabetic mice. I. Prevention of insulin-dependent diabetes.
    R B Pearce and C M Peterson
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 710-715;
  • You have access
    Studies of concanavalin A in nonobese diabetic mice. II. Lymphocyte tracking and phenotype responses.
    B Mukherjee, R B Pearce, B Formby and C M Peterson
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 716-721;
  • You have access
    Propafenone disposition and pharmacodynamics in normal and norepinephrine-induced cardiomyopathic rabbit hearts.
    A M Gillis, W M Lester and R Keashly
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 722-727;
  • You have access
    Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    R Godbout, J Mantz, S Pirot, J Glowinski and A M Thierry
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 728-738;
  • You have access
    Toxicity to isolated hepatocytes caused by the intracellular calcium indicator, Quin 2.
    L Carpenter-Deyo, J R Duimstra, O Hedstrom and D J Reed
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 739-746;
  • You have access
    Involvement of calcium and iron in Quin 2 toxicity to isolated hepatocytes.
    L Carpenter-Deyo and D J Reed
    Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 747-752;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 258, Issue 2
1 Aug 1991
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics